Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 20 | 2020 | 693 | 5.350 |
Why?
|
| Evidence-Based Medicine | 15 | 2020 | 3687 | 2.770 |
Why?
|
| Otitis Media with Effusion | 5 | 2017 | 115 | 2.100 |
Why?
|
| Hearing Loss, Sensorineural | 7 | 2017 | 781 | 2.000 |
Why?
|
| Rhinitis | 6 | 2020 | 747 | 1.720 |
Why?
|
| Sinusitis | 6 | 2020 | 991 | 1.550 |
Why?
|
| Hearing Loss | 7 | 2019 | 783 | 1.380 |
Why?
|
| Histamine Antagonists | 4 | 2017 | 90 | 1.320 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 265 | 1.170 |
Why?
|
| Otorhinolaryngologic Diseases | 3 | 2019 | 97 | 1.160 |
Why?
|
| Steroids | 2 | 2017 | 928 | 0.790 |
Why?
|
| Thyroidectomy | 9 | 2021 | 907 | 0.660 |
Why?
|
| Ambulatory Care | 3 | 2019 | 2775 | 0.620 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 1998 | 0.600 |
Why?
|
| Macrolides | 1 | 2017 | 205 | 0.530 |
Why?
|
| Decision Making | 4 | 2018 | 3929 | 0.520 |
Why?
|
| Medical History Taking | 1 | 2019 | 773 | 0.520 |
Why?
|
| Hearing Loss, Sudden | 1 | 2016 | 45 | 0.520 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 5492 | 0.520 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 20555 | 0.480 |
Why?
|
| Databases as Topic | 1 | 2016 | 473 | 0.460 |
Why?
|
| Recurrent Laryngeal Nerve | 3 | 2021 | 143 | 0.460 |
Why?
|
| Goiter | 2 | 2011 | 87 | 0.450 |
Why?
|
| Thyroid Neoplasms | 5 | 2021 | 2332 | 0.450 |
Why?
|
| Quality Improvement | 6 | 2018 | 3800 | 0.420 |
Why?
|
| Patient Preference | 1 | 2020 | 926 | 0.420 |
Why?
|
| Professional Competence | 1 | 2016 | 431 | 0.420 |
Why?
|
| Noise | 1 | 2014 | 290 | 0.390 |
Why?
|
| Gastroesophageal Reflux | 2 | 2016 | 816 | 0.390 |
Why?
|
| Educational Measurement | 2 | 2016 | 1254 | 0.370 |
Why?
|
| Thyroid Nodule | 2 | 2018 | 764 | 0.370 |
Why?
|
| Hearing | 1 | 2015 | 501 | 0.360 |
Why?
|
| Acetaminophen | 1 | 2015 | 554 | 0.360 |
Why?
|
| Ear Diseases | 2 | 2019 | 180 | 0.360 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2013 | 787 | 0.350 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 549 | 0.350 |
Why?
|
| Drug Utilization | 1 | 2016 | 1188 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 4 | 2017 | 7439 | 0.340 |
Why?
|
| Advisory Committees | 1 | 2014 | 785 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 8 | 2018 | 7389 | 0.340 |
Why?
|
| Neck | 1 | 2014 | 735 | 0.330 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2329 | 0.330 |
Why?
|
| Health Care Surveys | 4 | 2017 | 2426 | 0.330 |
Why?
|
| Probability | 4 | 2017 | 2478 | 0.320 |
Why?
|
| Thyroid Gland | 2 | 2018 | 1168 | 0.310 |
Why?
|
| Health Status | 2 | 2018 | 4075 | 0.310 |
Why?
|
| Head | 1 | 2014 | 924 | 0.310 |
Why?
|
| Chronic Disease | 6 | 2020 | 9319 | 0.300 |
Why?
|
| Lead | 1 | 2014 | 879 | 0.300 |
Why?
|
| Decision Trees | 2 | 2020 | 504 | 0.300 |
Why?
|
| Clinical Competence | 2 | 2016 | 4793 | 0.290 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2010 | 324 | 0.270 |
Why?
|
| Eustachian Tube | 2 | 2019 | 99 | 0.270 |
Why?
|
| Humans | 60 | 2021 | 761326 | 0.270 |
Why?
|
| Vocal Cord Paralysis | 3 | 2018 | 272 | 0.260 |
Why?
|
| Patient Participation | 1 | 2015 | 1443 | 0.260 |
Why?
|
| Nutritional Status | 1 | 2014 | 1613 | 0.250 |
Why?
|
| Administration, Intranasal | 2 | 2017 | 477 | 0.250 |
Why?
|
| Population Surveillance | 1 | 2015 | 2603 | 0.250 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2015 | 1871 | 0.250 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2319 | 0.240 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2273 | 0.240 |
Why?
|
| Endocrinology | 2 | 2021 | 442 | 0.240 |
Why?
|
| United States | 18 | 2021 | 72317 | 0.240 |
Why?
|
| Cytomegalovirus Infections | 1 | 2011 | 831 | 0.240 |
Why?
|
| Health Services Research | 6 | 2016 | 1811 | 0.240 |
Why?
|
| Inappropriate Prescribing | 2 | 2017 | 212 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2821 | 0.230 |
Why?
|
| Databases, Factual | 5 | 2016 | 7954 | 0.230 |
Why?
|
| Ear | 1 | 2004 | 172 | 0.230 |
Why?
|
| Quality of Life | 5 | 2021 | 13355 | 0.220 |
Why?
|
| Research Design | 2 | 2017 | 6178 | 0.220 |
Why?
|
| Ectodermal Dysplasia | 1 | 2004 | 106 | 0.220 |
Why?
|
| Adenoidectomy | 2 | 2014 | 167 | 0.220 |
Why?
|
| Genes, p16 | 1 | 2004 | 159 | 0.220 |
Why?
|
| Adenoids | 1 | 2003 | 35 | 0.220 |
Why?
|
| Cross-Sectional Studies | 8 | 2017 | 26108 | 0.210 |
Why?
|
| Child | 16 | 2021 | 80156 | 0.210 |
Why?
|
| Telemedicine | 1 | 2020 | 3041 | 0.210 |
Why?
|
| Aspirin | 1 | 2014 | 3134 | 0.210 |
Why?
|
| Thyroid Diseases | 2 | 2016 | 386 | 0.210 |
Why?
|
| ROC Curve | 2 | 2020 | 3572 | 0.200 |
Why?
|
| Poverty | 1 | 2014 | 2697 | 0.200 |
Why?
|
| Office Visits | 2 | 2016 | 595 | 0.190 |
Why?
|
| Male | 28 | 2021 | 360621 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2016 | 3429 | 0.180 |
Why?
|
| Laryngeal Neoplasms | 1 | 2004 | 514 | 0.170 |
Why?
|
| Female | 26 | 2020 | 392485 | 0.170 |
Why?
|
| Adult | 16 | 2021 | 221122 | 0.150 |
Why?
|
| Parathyroidectomy | 2 | 2021 | 242 | 0.150 |
Why?
|
| Consensus | 5 | 2021 | 3122 | 0.150 |
Why?
|
| Nasal Obstruction | 1 | 2019 | 159 | 0.150 |
Why?
|
| Administration, Oral | 2 | 2016 | 4013 | 0.150 |
Why?
|
| Gene Silencing | 1 | 2004 | 1509 | 0.140 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5247 | 0.140 |
Why?
|
| Antacids | 1 | 2016 | 94 | 0.130 |
Why?
|
| Resource Allocation | 1 | 2018 | 350 | 0.130 |
Why?
|
| Leukotriene Antagonists | 1 | 2016 | 124 | 0.130 |
Why?
|
| Vestibular Function Tests | 1 | 2016 | 128 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14665 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2016 | 5877 | 0.130 |
Why?
|
| Otosclerosis | 1 | 2016 | 113 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2019 | 1633 | 0.130 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 149 | 0.120 |
Why?
|
| RNA Interference | 1 | 2004 | 2832 | 0.120 |
Why?
|
| Young Adult | 6 | 2020 | 59196 | 0.120 |
Why?
|
| Endoscopy | 2 | 2014 | 1851 | 0.120 |
Why?
|
| Larynx | 2 | 2018 | 492 | 0.120 |
Why?
|
| Middle Aged | 15 | 2021 | 220774 | 0.120 |
Why?
|
| Meniere Disease | 1 | 2016 | 164 | 0.120 |
Why?
|
| Goiter, Substernal | 2 | 2011 | 17 | 0.120 |
Why?
|
| Risk Factors | 7 | 2017 | 74152 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2021 | 54405 | 0.120 |
Why?
|
| Audiometry | 1 | 2015 | 253 | 0.110 |
Why?
|
| Adolescent | 9 | 2021 | 88305 | 0.110 |
Why?
|
| Judgment | 1 | 2016 | 273 | 0.110 |
Why?
|
| Workflow | 1 | 2018 | 851 | 0.110 |
Why?
|
| Laryngoscopy | 2 | 2016 | 706 | 0.110 |
Why?
|
| Problem Solving | 1 | 2016 | 441 | 0.110 |
Why?
|
| Dizziness | 1 | 2016 | 259 | 0.110 |
Why?
|
| Documentation | 1 | 2019 | 897 | 0.110 |
Why?
|
| Tonsillectomy | 1 | 2016 | 277 | 0.110 |
Why?
|
| Middle Ear Ventilation | 1 | 2013 | 101 | 0.100 |
Why?
|
| Language Development | 1 | 2014 | 183 | 0.100 |
Why?
|
| Hypopharynx | 1 | 2012 | 53 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 415 | 0.100 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 1722 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 2 | 2018 | 2891 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 1165 | 0.100 |
Why?
|
| Logistic Models | 2 | 2017 | 13251 | 0.100 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2015 | 370 | 0.100 |
Why?
|
| Child, Preschool | 5 | 2016 | 42251 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2016 | 572 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20092 | 0.090 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 510 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2016 | 531 | 0.090 |
Why?
|
| Aged | 8 | 2021 | 169179 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 58946 | 0.090 |
Why?
|
| International Classification of Diseases | 4 | 2016 | 909 | 0.090 |
Why?
|
| Epistaxis | 1 | 2011 | 111 | 0.090 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2011 | 121 | 0.090 |
Why?
|
| Philosophy, Medical | 1 | 2010 | 79 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2015 | 2927 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 162 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 36430 | 0.080 |
Why?
|
| Maxillary Sinus | 1 | 2011 | 180 | 0.080 |
Why?
|
| Infant | 5 | 2021 | 36202 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 1728 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 1118 | 0.080 |
Why?
|
| Selection Bias | 1 | 2011 | 359 | 0.080 |
Why?
|
| Polysomnography | 1 | 2015 | 1847 | 0.080 |
Why?
|
| Postoperative Period | 1 | 2013 | 1813 | 0.080 |
Why?
|
| Review Literature as Topic | 1 | 2011 | 347 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2014 | 1887 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 4022 | 0.080 |
Why?
|
| Bandages | 1 | 2010 | 269 | 0.070 |
Why?
|
| Prevalence | 2 | 2015 | 15719 | 0.070 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 3889 | 0.070 |
Why?
|
| Specialties, Surgical | 1 | 2012 | 389 | 0.070 |
Why?
|
| Uncertainty | 1 | 2012 | 754 | 0.070 |
Why?
|
| Hematoma | 1 | 2011 | 768 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2015 | 6341 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2014 | 1958 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10498 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2011 | 661 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2014 | 10203 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1508 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3801 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2011 | 627 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 12972 | 0.060 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2004 | 153 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2015 | 9639 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2010 | 996 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9333 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2016 | 80575 | 0.050 |
Why?
|
| Cautery | 1 | 2003 | 71 | 0.050 |
Why?
|
| Delphi Technique | 2 | 2018 | 846 | 0.050 |
Why?
|
| Stilbamidines | 1 | 2002 | 43 | 0.050 |
Why?
|
| Heparin | 1 | 2010 | 1633 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12059 | 0.050 |
Why?
|
| Otitis Media | 1 | 2004 | 287 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 3249 | 0.050 |
Why?
|
| von Willebrand Diseases | 1 | 2003 | 132 | 0.050 |
Why?
|
| Fiber Optic Technology | 1 | 2003 | 290 | 0.050 |
Why?
|
| Retroviridae | 1 | 2004 | 850 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2013 | 15647 | 0.050 |
Why?
|
| Postoperative Care | 2 | 2018 | 1471 | 0.050 |
Why?
|
| Incidence | 2 | 2016 | 21336 | 0.050 |
Why?
|
| Age Factors | 2 | 2014 | 18401 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2004 | 1084 | 0.040 |
Why?
|
| Plasmids | 1 | 2004 | 2275 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2018 | 2242 | 0.040 |
Why?
|
| Neocortex | 1 | 2002 | 417 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 1923 | 0.040 |
Why?
|
| Somatosensory Cortex | 1 | 2002 | 512 | 0.040 |
Why?
|
| Mass Screening | 1 | 2014 | 5428 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 41440 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2010 | 3425 | 0.040 |
Why?
|
| Massachusetts | 1 | 2010 | 8837 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 2490 | 0.030 |
Why?
|
| Stapes Surgery | 1 | 2016 | 60 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7872 | 0.030 |
Why?
|
| Diagnostic Imaging | 2 | 2021 | 3531 | 0.030 |
Why?
|
| Electromyography | 1 | 2021 | 1393 | 0.030 |
Why?
|
| Bone Conduction | 1 | 2016 | 102 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2004 | 5034 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2016 | 210 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 6128 | 0.030 |
Why?
|
| Stroboscopy | 1 | 2016 | 62 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26211 | 0.030 |
Why?
|
| Transfection | 1 | 2004 | 5776 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15262 | 0.030 |
Why?
|
| North America | 1 | 2018 | 1275 | 0.030 |
Why?
|
| Otitis Media, Suppurative | 1 | 2013 | 27 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2004 | 3393 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2010 | 4813 | 0.030 |
Why?
|
| Vestibular Diseases | 1 | 2016 | 230 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 1086 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 931 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 23981 | 0.030 |
Why?
|
| Synapses | 1 | 2002 | 1769 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2013 | 292 | 0.030 |
Why?
|
| Speech Perception | 1 | 2016 | 507 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2013 | 587 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 1737 | 0.020 |
Why?
|
| Angiofibroma | 1 | 2011 | 55 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3588 | 0.020 |
Why?
|
| Hypoparathyroidism | 1 | 2011 | 136 | 0.020 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 290 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3905 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8223 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 1329 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 9458 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2016 | 5970 | 0.010 |
Why?
|
| Chlorophyllides | 1 | 2002 | 54 | 0.010 |
Why?
|
| Brain Tissue Transplantation | 1 | 2002 | 81 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2002 | 174 | 0.010 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2002 | 137 | 0.010 |
Why?
|
| Infrared Rays | 1 | 2002 | 247 | 0.010 |
Why?
|
| Reoperation | 1 | 2011 | 4302 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2002 | 350 | 0.010 |
Why?
|
| Porphyrins | 1 | 2002 | 352 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13500 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 785 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8470 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 665 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 14025 | 0.010 |
Why?
|
| Medicare | 1 | 2016 | 6758 | 0.010 |
Why?
|
| Lasers | 1 | 2002 | 951 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 2002 | 751 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1901 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5792 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 3818 | 0.010 |
Why?
|
| Cell Movement | 1 | 2002 | 5202 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 64645 | 0.000 |
Why?
|
| Apoptosis | 1 | 2002 | 9474 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2002 | 11531 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 22154 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18234 | 0.000 |
Why?
|
| Mice | 1 | 2002 | 81474 | 0.000 |
Why?
|
| Animals | 1 | 2002 | 168388 | 0.000 |
Why?
|
Concepts
(261)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_